The Joe Rogan ExperienceJoe Rogan Experience #2195 - Andrew Huberman
CHAPTERS
Dog breed genetics: wolves, mastiffs, and extreme size variation
Joe and Andrew start by unpacking how all dogs originate from wolves, but selective breeding emphasized morphology and temperament. Huberman highlights the enormous within-species size range in dogs and points to IGF-1–related genetics as a key lever.
Short snouts, pain tolerance, and why bulldogs struggle to breathe
Huberman explains how mastiff-heavy breeding contributes to brachycephalic (short-snouted) dogs and associated traits. They discuss pain receptor distribution, skin elasticity, and why many bulldogs exhibit sleep apnea-like breathing issues.
Dogs bred for jobs: bull-baiting origins, toy breeds, and ratters
The conversation shifts to what various breeds were historically designed to do, from guarding and herding to ratting and companionship. Huberman connects breeding goals to behavioral traits like loyalty, aggression, and pain tolerance.
Scent hounds and the mechanics of smell: ears, sniffs, and nose vortices
They pivot to hunting dogs and the anatomy/behavior that improves scent tracking. Joe explains long ears “wafting” odors, and Huberman describes how nostril structure creates vortices that keep odorants around longer.
Can humans track scents like dogs? The Berkeley chocolate-tracking experiments
Huberman describes research (Noam Sobel’s work) suggesting humans can track odors surprisingly well under constrained conditions. They discuss bilateral nostrils, sensory deprivation setup, and why old “humans have terrible smell” claims may be overstated.
Olfactory neurons, head trauma, COVID smell loss, and smell training (plus alpha-lipoic acid)
Using a deer skull and the cribriform plate as context, Huberman explains how smell neurons connect to the brain and why head hits can cause anosmia. They cover COVID-related smell loss, smell training protocols, and a debated supplement approach (alpha-lipoic acid).
Smelling salts demo: aversion reflex, adrenaline surge, and nostril dominance switching
Joe introduces extremely strong smelling salts and both try them on-air. Huberman uses the experience to explain aversive olfactory pathways, adrenaline release, and research suggesting dominant airflow alternates between nostrils every couple hours with autonomic-state shifts.
Fighters, pain, and pattern recognition: liver shots, question-mark kicks, and Mayweather’s timing
Smelling salts lead into combat physiology: adrenaline as a pain modulator and how fighters operate under impact. Joe breaks down liver-shot dynamics, deceptive kicking mechanics, and why elite boxing defense is both technique and learned pattern recognition.
Anger as a reward and the “high-conflict” personality problem in relationships
They discuss a study suggesting people may find anger/frustration reinforcing, connecting it to social media dynamics. Huberman then outlines concepts from a book about ‘high conflict’ people and practical heuristics to avoid manipulation and toxic relationship patterns.
Sauna, cold plunge, and doing hard things: the anterior mid-cingulate cortex and “SuperAgers”
They move into recovery rituals and why temperature exposure changes alertness and sleep. Huberman connects “doing what you don’t want to do” to growth in the anterior mid-cingulate cortex and correlates with preserved cognition in ‘SuperAgers.’
Nootropics and stimulants: Alpha-GPC, theanine, modafinil, nicotine, and dopamine management
The conversation expands to cognitive enhancers and stimulant-like tools, from supplements to prescription wakefulness drugs. Huberman emphasizes catecholamines’ coordinated roles and warns about tolerance, escalation, and the dopamine ‘trough’ problem.
Media manipulation, out-of-context edits, and scientific fraud parallels (from MSNBC to Pingtrip)
Joe and Huberman discuss deceptive editing in political media and viral clip culture, contrasting satire/remix art with propaganda-like distortions. Huberman draws a line to scientific integrity issues—selection bias, pressure in labs, and occasional outright fraud.
Health interventions and psychedelics: GLP-1 drugs, seed oils, MDMA/PTSD safeguards, and cannabis nuance
They close this segment by weighing pharmaceuticals against behavioral fundamentals while acknowledging legitimate therapeutic breakthroughs. Topics include GLP-1 appetite drugs, the evidentiary debate on seed oils, MDMA-assisted therapy’s control/safety issues, and cannabis risks (notably psychosis and edibles).
